| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GMED | Class A Common Stock | Options Exercise | $703K | +14.2K | $49.65 | 14.2K | Feb 2, 2023 | Direct | ||
| transaction | GMED | Class A Common Stock | Options Exercise | $799K | +15K | +105.88% | $53.27 | 29.2K | Feb 2, 2023 | Direct | |
| transaction | GMED | Class A Common Stock | Sale | -$2.26M | -29.2K | -100% | $77.57 | 0 | Feb 2, 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GMED | Stock Option (Right to Buy Class A Common Stock) | Options Exercise | $0 | -14.2K | -70.84% | $0.00 | 5.83K | Feb 2, 2023 | Class A Common Stock | 14.2K | $49.65 | Direct | F3 |
| transaction | GMED | Stock Option (Right to Buy Class A Common Stock) | Options Exercise | $0 | -15K | -62.07% | $0.00 | 9.17K | Feb 2, 2023 | Class A Common Stock | 15K | $53.27 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.885, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
| F3 | These options were granted on September 3, 2019 and are fully vested. |
| F4 | These options were granted on January 22, 2020 and are fully vested. |